Skip to main content

Table 3 Soldier cases compared by presence versus absence of post-acute sequelae of SARS-CoV-2 infection (CV PASC)

From: Cardiovascular magnetic resonance evaluation of soldiers after recovery from symptomatic SARS-CoV-2 infection: a case–control study of cardiovascular post-acute sequelae of SARS-CoV-2 infection (CV PASC)

  CV PASC
(N = 7)
No PASC
(N = 12)
P value
LVEF, median (IQR), % 57.8 (57.1, 63.1) 57.9 (54.7, 61.5) 0.45
LVEDV, mL 168.1 (164.3, 207.7) 184.6 (168.1, 206.3) 0.61
LVEDVI, mL/m2 84.3 (82.5, 96.0) 84.3 (81.9, 95.2) 0.61
LVESV, mL 69.0 (64.3, 81.1) 74.6 (65.5, 92.1) 0.35
LVESVI, mL/m2 34.8 (32.2, 38.3) 36.4 (32.4, 40.5) 0.53
LV mass, g 136.4 (127.3, 158.2) 130.5 (126.2, 140.5) 0.47
LV mass index, g/m2 64.8 (62.6, 74.8) 62.5 (58.7, 66.7) 0.16
RVEF, % 50.6 (48.3, 52.0) 50.5 (46.9, 53.2) 0.87
RVEDV mL 221.0 (192.2, 276.3) 208.6 (188.3, 226.0) 0.40
RVEDVI, mL/m2 107.9 (94.9, 129.3) 99.6 (88.0, 105.8) 0.24
RVESV, mL 110.3 (95.1, 135.7) 105.3 (90.3, 114.4) 0.55
RVESVI, mL/m2 55.3 (45.6, 63.5) 48.4 (47.5, 53.5) 0.35
T1, median (IQR), ms    
 Mid septum 986.4 (958.5, 1007.7) 985.6 (964.0, 994.1) 0.74
 Mid lateral 970.2 (962.2, 983.7) 973.1 (944.6, 1001.0) 0.80
 Mid global 972.1 (956.0, 1003.6) 978.5 (953.9, 996.3) 0.99
T2 median (IQR), ms    
 Mid septum 45.7 (45.0, 47.4) 44.7 (43.8, 45.7)b 0.10
 Mid lateral 45.5 (44.6, 45.6) 45.6 (43.8, 46.1)b 0.62
 Mid global 45.7 (44.8, 47.5) 45.3 (44.1, 46.1)b 0.10
ECV (global), %    
 Mid septum 25.4 (24.1, 26.1)a 23.4 (22.3, 25.3)b 0.12
 Mid lateral 23.0 (22.5, 24.2)a 22.1 (20.5, 22.5)b 0.06
 Mid global 23.9 (22.0, 25.7)a 23.0 (21.3, 23.4)c 0.36
LGE    
 Any, N (%) 3 (42.9%) 1 (9.1%)b 0.25
 Inferior RV septal insertion 1 (14.3%) 1 (9.1%)b 0.99
 Subepicardial inferolateral 2 (28.6%) 0 (0%)b 0.14
Diagnosis    
 Myocarditis 2 (28.6%) 0 (0%)b 0.14
  1. aN = 6
  2. bN = 11
  3. cN = 10